Education
About Us
Working with TipRanks
Follow Us
Outset Medical (OM)
NASDAQ:OM
OM Stock Chart & Stats
$4.34
-$0.10(-9.09%)
At close: 4:00 PM EST
$4.34
-$0.10(-9.09%)
Day’s Range― - ―
52-Week Range$3.10 - $21.98
Previous CloseN/A
Volume1.92M
Average Volume (3M)435.07K
Market Cap
$78.69M
Enterprise Value$217.81M
Total Cash (Recent Filing)$178.64M
Total Debt (Recent Filing)$3.16M
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Feb 17, 2026EPS Estimate
-0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding18,153,090
10 Day Avg. Volume400,994
30 Day Avg. Volume435,066
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.15
Price to Sales (P/S)0.51
P/FCF Ratio-0.49
Enterprise Value/Market Cap2.77
Enterprise Value/Revenue1.81
Enterprise Value/Gross Profit4.81
Enterprise Value/Ebitda-3.12
Forecast
1Y Price Target
$11.75Price Target Upside170.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical ValidationNew clinical findings presented at a major nephrology conference reinforced the Tablo System’s effectiveness for insourced dialysis, supporting its differentiated value proposition and adoption case.
Profitability And Cash ManagementImproved gross margins combined with significantly lower operating expenses point to improving profitability and reduced cash burn, easing near-term financing pressures.
Revenue GrowthConsole revenue returned to growth and outperformed analyst expectations, indicating strengthening demand and a healthy deal pipeline for enterprise deployments.
Bears Say
Consumables DemandConsumables revenue softened due to a disconnect between orders and actual usage, signaling inconsistent recurring demand that could pressure long-term revenue sustainability.
Order Timing RiskQuarterly revenue shortfalls driven by order timing issues created uncertainty in topline momentum and clouded the visibility of recurring revenue trends.
Salesforce DisruptionDeparture of the head of sales raises the risk of salesforce disruption during a critical period, which could delay enterprise deal execution and slow new customer acquisition.
Outset Medical News
OM FAQ
What was Outset Medical’s price range in the past 12 months?
Outset Medical lowest stock price was $3.10 and its highest was $21.98 in the past 12 months.
What is Outset Medical’s market cap?
Outset Medical’s market cap is $78.69M.
When is Outset Medical’s upcoming earnings report date?
Outset Medical’s upcoming earnings report date is Feb 17, 2026 which is in 39 days.
How were Outset Medical’s earnings last quarter?
Outset Medical released its earnings results on Nov 10, 2025. The company reported -$0.69 earnings per share for the quarter, missing the consensus estimate of -$0.655 by -$0.035.
Is Outset Medical overvalued?
According to Wall Street analysts Outset Medical’s price is currently Undervalued.
Does Outset Medical pay dividends?
Outset Medical does not currently pay dividends.
What is Outset Medical’s EPS estimate?
Outset Medical’s EPS estimate is -0.68.
How many shares outstanding does Outset Medical have?
Outset Medical has 18,153,090 shares outstanding.
What happened to Outset Medical’s price movement after its last earnings report?
Outset Medical reported an EPS of -$0.69 in its last earnings report, missing expectations of -$0.655. Following the earnings report the stock price went down -48.467%.
Which hedge fund is a major shareholder of Outset Medical?
Currently, no hedge funds are holding shares in OM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Outset Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.75 (170.74% Upside)
$11.75 (170.74% Upside)
Blogger Sentiment
Bullish
OM Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 15.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $23.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.9%
Last 30 Days ▲ 25.6%
Last 30 Days ▲ 25.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-73.69%
12-Months-Change
Fundamentals
Return on Equity
-92.33%
Trailing 12-Months
Asset Growth
-5.34%
Trailing 12-Months
Company Description
Outset Medical
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
OM Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook for Outset Medical. While there were positives such as increased console sales, improved gross margins, and a strong cash position, the company faced challenges with revenue growth, leadership changes, and deal closing timing. The uncertainty about future sales leadership and the revision of revenue guidance contributed to a cautious outlook.View all OM earnings summariesOM Revenue Breakdown
47.04% Consoles
32.37% Consumables
20.59% Service and other revenue
OM Stock 12 Month Forecast
Average Price Target
$11.75
▲(170.74% Upside)
Technical Analysis
Ownership Overview
4.06% Insiders
25.29% Mutual Funds
42.60% Other Institutional Investors
18.67% Public Companies and
Individual Investors